302440.KS
SK bioscience Co.,Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 36,250.00
+0.14%Next report
Analyst consensus
- Next report date
- Oct 22, 2026
- EPS estimate
- -KRW 454
- Revenue estimate
- KRW 179.0B
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -KRW 310
- EPS estimate
- -KRW 341
- Revenue actual
- KRW 155.7B
- Revenue estimate
- KRW 180.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +9.1%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -KRW 341 | -KRW 310 | Beat 9.08% | KRW 155.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 22, 2026